Trends in pharmacotherapy utilization among patients with heart failure with preserved ejection fraction.

ABSTRACT:

Study objective

Half of patients with heart failure have preserved ejection fraction (HFpEF). Over the years, guidelines have recommended or advised against various therapies for HFpEF management. However, there is limited evidence on the trends in utilization of the various medications. The aim of this study was to examine the trends in the use of pharmacotherapies among patients with HFpEF from 2008 through 2020.

Design

Retrospective cohort study of patients with HFpEF used MarketScan® Commercial and Medicare Supplemental Databases (2007-2020).

Participants

Patients with HFpEF.

Outcome measures

Utilization rates for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), angiotensin receptor-neprilysin inhibitors (ARNIs), aldos

SUBMITTER: Riaz M 

PROVIDER: S-EPMC10946036 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature